Clinical trial
HyperAldosteronism in Pregnancy Predicted Impacts
NCT05636995 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HyperAldosteronism in Pregnancy Predicted Impacts
- Lead sponsor
- Université de Sherbrooke
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 10, 2023
- Completion date
- December 31, 2025
- Enrollment
- 200 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hypertensive disorder of pregnancy, primary hyperaldosteronism